| Debra A Szymanski, DO | |
|
Pmg San Mateo, 401 San Mateo Blvd Se, Albuquerque, NM 87108 | |
| (505) 462-7333 | |
| (505) 462-7495 |
| Full Name | Debra A Szymanski |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | Pmg San Mateo, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306955638 | NPI | - | NPPES |
| 45707375 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | A-1207-03 (New Mexico) | Primary |
| Entity Name | Presbyterian Healthcare Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104802354 PECOS PAC ID: 9234041708 Enrollment ID: O20031103000603 |
News Archive
Walking at an easy pace for about three hours every week may be just enough physical activity to help prostate cancer survivors reduce damaging side effects of their treatment, according to a new Northwestern Medicine study.
Apixaban, an oral anticoagulant being developed by Bristol-Myers Squibb Company and Pfizer Inc., was statistically superior to 40 mg once daily enoxaparin in reducing the incidence of venous thromboembolism in patients undergoing elective total knee replacement surgery, according to the ADVANCE-2 study results published today in The Lancet. The study results also showed numerically lower rates of major and clinically relevant non-major bleeding in patients treated with apixaban compared with those treated with enoxaparin.
Megan Fotheringham, a public health adviser with the President's Malaria Initiative, describes in a post on USAID's "IMPACTblog" how a program in Kenya worked to improve the successful administration of malaria prevention therapy among pregnant women in the country's Gem District simply by sending to antenatal clinics a memo describing when to administer the treatment.
Smart Disc, Inc., a Michigan-based medical technology company focused on the development of new and innovative spine products, announced today that it has been awarded Patent US 7,407,513 B2 for Smart Disc's unique artificial spinal disc technology.
Pelvalon announced today that the U.S. Food and Drug Administration has granted the company's de novo request to market the Eclipse System, the first vaginal insert designed to provide bowel control, in the United States. Loss of bowel control, also known as fecal incontinence, is a condition that affects over 20 million women in the U.S.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Debra A Szymanski, DO Po Box 26666, Phs Provider Enrollment, Albuquerque, NM 87125-6666 Ph: (505) 923-5356 | Debra A Szymanski, DO Pmg San Mateo, 401 San Mateo Blvd Se, Albuquerque, NM 87108 Ph: (505) 462-7333 |
News Archive
Walking at an easy pace for about three hours every week may be just enough physical activity to help prostate cancer survivors reduce damaging side effects of their treatment, according to a new Northwestern Medicine study.
Apixaban, an oral anticoagulant being developed by Bristol-Myers Squibb Company and Pfizer Inc., was statistically superior to 40 mg once daily enoxaparin in reducing the incidence of venous thromboembolism in patients undergoing elective total knee replacement surgery, according to the ADVANCE-2 study results published today in The Lancet. The study results also showed numerically lower rates of major and clinically relevant non-major bleeding in patients treated with apixaban compared with those treated with enoxaparin.
Megan Fotheringham, a public health adviser with the President's Malaria Initiative, describes in a post on USAID's "IMPACTblog" how a program in Kenya worked to improve the successful administration of malaria prevention therapy among pregnant women in the country's Gem District simply by sending to antenatal clinics a memo describing when to administer the treatment.
Smart Disc, Inc., a Michigan-based medical technology company focused on the development of new and innovative spine products, announced today that it has been awarded Patent US 7,407,513 B2 for Smart Disc's unique artificial spinal disc technology.
Pelvalon announced today that the U.S. Food and Drug Administration has granted the company's de novo request to market the Eclipse System, the first vaginal insert designed to provide bowel control, in the United States. Loss of bowel control, also known as fecal incontinence, is a condition that affects over 20 million women in the U.S.
› Verified 4 days ago
Janell Fuller, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3rd Ambulatory Care Ctr, 2211 Lomas Blvd. Ne, Albuquerque, NM 87131 Phone: 505-272-2345 | |
Ivana Radovanovic, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2211 Lomas Ne Acc 3w, Albuquerque, NM 87131 Phone: 505-272-6632 Fax: 505-272-6620 | |
Lynn Longfield, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4420 Irving Blvd Nw, Albuquerque, NM 87114 Phone: 505-823-1010 Fax: 505-797-4503 | |
Thomas Rothfeld, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 401 San Mateo Blvd Se, Pmg San Mateo, Albuquerque, NM 87108 Phone: 505-462-7306 Fax: 505-462-7495 | |
Dr. Leslie Erin Strickler, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 2211 Lomas Blvd Ne, Albuquerque, NM 87106 Phone: 505-272-5551 Fax: 505-272-6845 | |
Jennifer M Garcia, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2001 El Centro Familiar Blvd Sw, Albuquerque, NM 87105 Phone: 505-873-7400 Fax: 505-224-8797 | |
Dr. William B Hawk, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5904 Holly Ave Ne, Albuquerque, NM 87113 Phone: 505-298-2505 Fax: 505-298-2985 |